Identification of Umbilical Cord Blood Biomarkers for Early-Onset Sepsis in Preterm Infants
New research identifies specific proteins in umbilical cord blood as early biomarkers for sepsis in preterm infants, enabling rapid and noninvasive diagnosis to improve neonatal care.
Researchers from the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago have made significant progress in diagnosing early-onset sepsis in preterm newborns. They identified specific proteins in umbilical cord blood that serve as indicators of systemic inflammation caused by infection. This discovery offers a noninvasive and rapid method for detecting sepsis, enabling more accurate diagnoses before clinical symptoms become apparent.
Early-onset sepsis, which occurs within the first 72 hours after birth, is more prevalent among preterm infants. It often initiates in utero, frequently triggered by intra-amniotic infections. Because clinical signs are unreliable for definitive diagnosis, antibiotics are routinely administered while awaiting culture results. However, in many cases, antibiotics are continued even if cultures are negative, exposing infants to unnecessary treatment.
The study highlighted that analyzing cord blood for specific biomarkers could provide results within 24 hours. This allows healthcare providers to confidently rule out sepsis and discontinue antibiotics when appropriate, reducing unnecessary exposure and potential risks like microbiome disruption and immune dysregulation.
In addition, the researchers developed a machine learning algorithm based on these biomarkers and associated risk factors. This innovative diagnostic tool, currently pending a patent, aims to enhance early detection accuracy. The next steps involve validating these findings through multicenter studies and clinical trials.
Lead author Dr. Leena B. Mithal emphasized the potential impact of this advancement, stating that cord blood biomarkers could significantly improve neonatal care, especially for premature infants. Co-author Patrick Seed, MD, Ph.D., and other collaborators continue to work toward integrating this technology into clinical practice, ultimately promising a more precise, swift, and less invasive approach to diagnosing neonatal sepsis.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
NYC Outbreak of Legionnaires' Disease Results in Five Fatalities
A recent Legionnaires' disease outbreak in Harlem, New York City, has led to five fatalities and numerous hospitalizations. The outbreak is linked to contaminated cooling towers, emphasizing the need for proper water system maintenance. Officials continue to investigate and manage the situation to prevent further cases.
USDA Discontinues Annual Hunger and Food Security Reports in the United States
The USDA has ceased publishing its historic annual reports on food insecurity in the U.S., raising concerns about the impact on understanding and addressing hunger nationwide.
Innovative Blood Test Using Metabolite Analysis Promises Early COPD Detection for Population Screening
A new blood metabolite analysis method shows promise for early detection of COPD, potentially revolutionizing population screening and improving patient outcomes through non-invasive testing.